Nordic Lymphoma Group
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01) (NCT06755619) | Nordic Lymphoma Group | 2025-01-01 |
| Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma (NCT05214183) | Nordic Lymphoma Group | 2021-12-15 |
| A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma (NCT04332822) | Nordic Lymphoma Group | 2020-08-19 |
| Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma (NCT03505944) | Nordic Lymphoma Group | 2018-07-01 |
Track Nordic Lymphoma Group automatically
Every clearance here is in the API, with alerts when new ones post.